SCHEMBL13286572

SCHEMBL13286572

CCC(=O)C(=O)NCCCC(=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G4A P47712 1/20 0.68
▸ PLA2G2A P14555 3/20 0.62
▸ EPHX2 P34913 1/20 0.49
▸ ADRA1A P35348 1/20 0.48
▸ PRMT1 Q99873 1/20 0.47
▸ AKR1B1 P15121 1/20 0.43
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MAPT P10636 1/20 0.41
▸ SLC6A5 Q9Y345 1/20 0.41
▸ PPARG P37231 6/20 0.41
▸ PPARD Q03181 6/20 0.41
▸ PPARA Q07869 6/20 0.41
▸ GPR84 Q9NQS5 5/20 0.41
▸ HDAC11 Q96DB2 5/20 0.41
▸ TSHR P16473 4/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ TLR2 O60603 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ FABP4 P15090 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26253430 0.84 MEN1 (0.50) PLA2G4APLA2G2AMEN1KMT2A
SCHEMBL1877382 0.81 PLA2G4A (1.00) PLA2G4APLA2G2AEPHX2AKR1B1MEN1
SCHEMBL2770529 0.81 PLA2G4A (1.00) PLA2G4APLA2G2AEPHX2AKR1B1MEN1
SCHEMBL25783478 0.80 PLA2G2A (0.53) PLA2G4APLA2G2AEPHX2MEN1KMT2A
SCHEMBL13286569 0.80 TSHR (0.52) PLA2G4APLA2G2AEPHX2TSHRALDH1A1
SCHEMBL13991907 0.80 PLA2G4A (0.54) PLA2G4APLA2G2AEPHX2MEN1KMT2A
SCHEMBL1912627 0.78 MEN1 (0.70) PLA2G4APLA2G2AEPHX2ADRA1APRMT1
SCHEMBL13991893 0.78 PLA2G4A (0.57) PLA2G4APLA2G2AEPHX2MEN1KMT2A
SCHEMBL28254961 0.78 PLA2G4A (0.55) PLA2G4APLA2G2AEPHX2ADRA1APRMT1
SCHEMBL28776220 0.77 PLA2G2A (1.00) PLA2G4APLA2G2AEPHX2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745489-B2 Compositions and methods for inhibition of phospholipase A2 mediated inflammation THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-06-29 — — US disclosed
US-20080319065-A1 Systemic and Intrathecal Effects of a Novel Series of Phospholipase A2 Inhibitors on Hyperalgesia and Spinal Pge2 Release THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080319065-A1 Systemic and Intrathecal Effects of a Novel Series of Phospholipase A2 Inhibitors on Hyperalgesia and Spinal Pge2 Release PLA2G4A, PLA2G4B, PLA2G2A PLA2G4A 1/4885PLA2G2A 3/4885EPHX2 140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback